Sign in

CIK 0001582313

  • Large accelerated filer

Xenon Pharmaceuticals Inc.

Sign in to watch
Ticker
XENE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
British Columbia, Canada
Entity type
Operating
EIN
980661854
Phone
+1 604-484-3300
Business address
200 - 3650 GILMORE WAY, BURNABY, British Columbia, Canada
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Exercise or conversion Director acquired 2,469 shares (option exercise)
  6. 4 Exercise or conversion Director acquired 2,057 shares (option exercise)
  7. 4 Exercise or conversion Director acquired 3,497 shares (option exercise)
  8. 4 Exercise or conversion Director acquired 5,041 shares (option exercise)
  9. 4 Open-market sale VP of Clinical Development sold 22,149 shares at an average $8.88 ($196,664)
  10. 4 Exercise or conversion SVP Bus. & Corp. Development acquired 3,085 shares (option exercise)
  11. 4 Exercise or conversion President & CEO acquired 20,576 shares (option exercise)
  12. 4 Exercise or conversion Director acquired 2,057 shares (option exercise)
  13. 4 Exercise or conversion VP of Clinical Development acquired 3,085 shares (option exercise)
  14. 4 Exercise or conversion Director acquired 1,543 shares (option exercise)
  15. 4 Derivatives Options or other derivatives
  16. 3 Insider Initial Statement of Ownership
  17. 4 Derivatives Options or other derivatives
  18. 4 Insider Changes in Ownership
  19. 4 Insider Changes in Ownership
  20. 4 Insider Changes in Ownership

Page 16 of 19 · 370 filings